Pacific Biosciences of California PACB Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $12.47M-41.5% | $14.76M-38.0% | $16.05M-42.9% | $19.95M-32.9% | $21.32M-34.6% | ||
| -$128.58M+80.5% | -$546.38M-75.0% | -$506.01M-28.3% | -$528.73M-32.1% | -$660.12M-122% | ||
| -$119.15M+71.6% | -$171.43M+60.4% | -$277.32M+24.5% | -$294.95M+25.0% | -$419.27M-40.8% | ||
| -$133.28M+83.8% | -$553.86M-16.8% | -$665.69M-62.8% | -$690.89M-61.7% | -$821.89M-153% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Pacific Biosciences of California's revenue?
- Pacific Biosciences of California (PACB) generated $160.0M in revenue over the trailing twelve months, up 5.0% year over year.
- Is Pacific Biosciences of California profitable?
- Pacific Biosciences of California is not currently profitable: it reported a net loss of $128.6M over the trailing twelve months, a -80.3% net margin.
- What are Pacific Biosciences of California's profit margins?
- Gross margin is 37.5% and operating margin is -83.3%, with a -80.3% net margin.
- What is Pacific Biosciences of California's earnings per share?
- Pacific Biosciences of California's diluted EPS over the trailing twelve months is $-0.43.
- Where does Pacific Biosciences of California's income statement data come from?
- Every line is extracted from Pacific Biosciences of California's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
